Cargando…
Enhancing B-Cell Malignancies—On Repurposing Enhancer Activity towards Cancer
SIMPLE SUMMARY: B-cell malignancies are a heterogenous group of lymphomas and leukemias and are the 6th most common cancer-related cause of death. Apart from several oncogenes and tumor suppressors involved in their pathogenesis, recently the role of non-coding, regulatory sequences has been implied...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269369/ https://www.ncbi.nlm.nih.gov/pubmed/34210001 http://dx.doi.org/10.3390/cancers13133270 |